Veterinary Medicine Information website

Primun Newcastle C30 Lyophilisate for suspension

Authorised
  • Newcastle disease virus, strain NDV_CLS, Live
Download as PDF

Product identification

Medicine name:
Primun Newcastle C30 Lyophilisate for suspension
Active substance:
  • Newcastle disease virus, strain NDV_CLS, Live
Target species:
  • Chicken
Route of administration:
  • Oculonasal use
  • Nebulisation use
  • In drinking water use

Product details

Active substance and strength:
  • Newcastle disease virus, strain NDV_CLS, Live
    6.00
    log 10 50% embryo infective dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for oculonasal suspension/use in drinking water
Withdrawal period by route of administration:
  • Oculonasal use
    • Chicken
      • Meat and offal
        0
        day
      • Egg
        0
        day
  • Nebulisation use
    • Chicken
      • Egg
        0
        day
      • Meat and offal
        0
        day
  • In drinking water use
    • Chicken
      • Egg
        0
        day
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:
  • (ID1) 1000 Dose: Box (cardboard) with 1 Bottle (Glass type I) with 1000 Dose, closed with Stopfen (bromobutyl rubber) and Kappe (aluminium) and Deckel (No information)
  • (ID2) 10000 Dose: Box (cardboard) with 10 Bottle (Glass type I) each with 1000 Dose, closed with Stopfen (bromobutyl rubber) and Kappe (aluminium) and Deckel (No information)
  • (ID5) 5000 Dose: Box (cardboard) with 1 Bottle (Glass type I) with 5000 Dose, closed with Stopfen (bromobutyl rubber) and Kappe (aluminium) and Deckel (No information)
  • (ID6) 50000 Dose: Box (cardboard) with 10 Bottle (Glass type I) each with 5000 Dose, closed with Stopfen (bromobutyl rubber) and Kappe (aluminium) and Deckel (No information)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Laboratorios Calier S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Calier S.A.
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 2836
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0273/001
Concerned member states:
  • Italy
  • Poland
  • Portugal
  • Spain

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 24/11/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 24/11/2025
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 24/11/2025
Download

Combined File of all Documents

English (PDF)
Published on: 10/03/2026
Download

2613836-paren-20260201.pdf

English (PDF)
Published on: 10/03/2026
Download